Sorafenib Accord

Sorafenib Accord is an oral medication used for certain types of cancer. It belongs to the kinase inhibitor class and is prescribed to help manage advanced kidney or liver cancer. This product is manufactured by Accord Healthcare S.L.U. and is available for oral use.

Sorafenib Accord is primarily used to treat advanced renal cell carcinoma, a type of kidney cancer. It may also be prescribed for unresectable hepatocellular carcinoma, a form of liver cancer. Patients often ask, 'what is Sorafenib used for' to understand its role in cancer treatment. This medication works by slowing or stopping the growth of cancer cells.

Sorafenib Accord may help reduce the progression of certain cancers by targeting specific proteins involved in tumor growth. Some patients experience side effects such as fatigue, nausea, or skin reactions. These effects vary and should be monitored by a healthcare provider. It is not intended to cure cancer but to manage the disease.

Store Sorafenib Accord at room temperature away from moisture and heat. Keep this medication out of reach of children and pets. Avoid crushing or splitting tablets unless directed by a healthcare professional. Always follow the handling instructions provided with the medication.

Sorafenib Accord may interact with other medications, including certain blood thinners, antidepressants, and CYP3A4 inhibitors. Alcohol and grapefruit products may also affect how this drug works. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.